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Posterior spinal instrumented fusion for idiopathic scoliosis in patients with multisystemic neurodegenerative disorder: a report of two cases To the Editor : We read with interest the article by Loh et al. 1 In the study, 2 paediatric patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (MELAS) syndrome underwent surgical stabilisation for scoliosis, presumed to be related to the m.3243A>G mutation. Scoliosis is an unusual feature in patients carrying the m.3243A>G mutation. We are not aware of other scoliotic patients with MELAS syndrome or the m.3243A>G mutation. Nonetheless, scoliosis has been occasionally reported in patients with mitochondrial disorders (MID) due to mutations in genes other than the tRNA(Leu), such as SUCLA2 or NDUFV1, 2,3 or patients carrying multiple mtDNA deletions. 4 Scoliosis also seems to be very prevalent in patients with Leigh syndrome. 3, 5 Patients with a MID are prone to develop scoliosis if the MID manifests as myopathy and if myopathy predominantly affects the axial muscles. 6 Paraspinal muscles are crucial to the development of scoliosis, as they are particularly susceptible to age-related respiratory chain defects attributable to clonally expanded mtDNA deletions or focal mtDNA depletion. 7 Did the authors consider causes such as muscular dystrophies, congenital myopathies, or myofibrillar myopathies. 8, 9 Did either of the 2 patients undergo muscle biopsy of the paraspinal muscles to confirm mitochondrial myopathy as the cause of scoliosis? Were biochemical investigations of the muscle homogenate carried out to assess which of the respiratory chain complexes was deficient? An argument against MELAS syndrome as the cause of scoliosis in these 2 patients is that the heteroplasmy rate of 50% was low in patient 1, and not provided in patient 2.
Family history of the patients should have been provided. Was any of the first-degree relatives a carrier of the m.3243A>G mutation and did these mutation carriers also present with scoliosis? A strong argument for the m.3243A>G mutation as the cause of scoliosis would be the segregation of the mutation with scoliosis, although this was obviously not the case in this family.
Patients with a MID should not receive propofol at a high dose over a prolonged period of time, although short-term application should be safe. 10 Nonetheless, MID patients are at higher risk of developing a propofol infusion syndrome. 10 Patients with a propofol infusion syndrome should be screened for MIDs. 10 Further diagnostic work-up for muscle biopsy and biochemistry should have been provided, as should family history and screening for the MELAS mutation and for scoliosis. 
